Dr. Lee Ann Shing - Clinical Oncology
Specialist in Clinical Oncology
Highlights
- MCHK RegisteredVerified
- Specialist in Clinical OncologyBachelor of Medicine and Bachelor of Surgery (MBChB) · Hong Kong College of Radiologists · Medical degree 1992
- InsuranceBeing compiled｜See details
About
Dr. Lee Ann Shing is a registered Clinical Oncology specialist in Hong Kong.
Education
Specialist in Clinical Oncology
- Bachelor of Medicine and Bachelor of Surgery (MBChB)Bachelor of Medicine and Bachelor of Surgery (MBChB)1992
Hong Kong Academy of Medicine fellowships
- FHKCRFellow, Hong Kong College of Radiologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Lee Ann Shing? Claim page and update insurance →
FAQ
Is Dr. Lee Ann Shing any good?
Dr. Lee Ann Shing is a registered Clinical Oncology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Lee Ann Shing do?
Dr. Lee Ann Shing practises in Clinical Oncology.
Are you Dr. Lee Ann Shing? Claim this page to update and manage.
ClaimResearch and publications
7 papers
- The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021.Hepatobiliary surgery and nutrition · 2023
- Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis.Surgical oncology · 2019
- Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma.Liver cancer · 2018
- Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting.Liver cancer · 2017
- Comparison of clinical efficacy and renal safety of telbivudine and entecavir in chronic hepatitis B patients receiving cytotoxic chemotherapy.Journal of digestive diseases · 2016
- Hong Kong consensus recommendations on the management of hepatocellular carcinoma.Liver cancer · 2015
- Severe ileitis associated with capecitabine: Two case reports and review of the literature.Molecular and clinical oncology · 2015
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer